Biological differences between the sexes should be taken into account when testing and administering drugs and vaccines, argues Sabra Klein, associate professor of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health.
Klein and other researchers around the world have found men and women respond differently to pathogens and therapies, “no matter whether we’re looking at Zika, malaria, flu, lupus or heart disease,” she writes.
To calibrate treatment and prevention for women’s and men’s bodies, she says, “We need to design research studies from the outset to compare the sexes by making an a priori hypothesis that males and females will be different.”
Source: Hopkins Bloomberg Public Health Magazine

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top